This high degree of tumor heterogeneity is attributed to the liver’s four distinct epithelial cell types (hepatocytes, mucin-producing or non-mucin-producing cholangiocytes, and hepatic progenitor cells (HPCs)), which can give rise to PLCs in the context of chronic liver diseases with various etiologies [20,21,22]. Here, MUC5AC is linked to neoplasm.